The experimental mRNA vaccine prevented 60% to 67% of flu infections, while the conventional vaccine prevented 44% to 54% of ...

Each year, as Americans roll up their sleeves for their annual flu shot, they might be surprised to learn their protection ...

Health secretary RFK Jr. wants other countries to ban the use of the preservative thimerosal in vaccines, despite research showing it is a safe ingredient.

The global cell culture media market size is expected to reach USD 12.80 billion by 2033, registering a CAGR of 13.20% from 2025 to 2033, according to a new report by Grand View Research, Inc. Cell ...

Cuts to funding and personnel at the US Centers for Disease Control and Prevention are endangering the public’s health and ...

Turkeys make up approximately 2% of the entire U.S. poultry inventory, but account for 24% of new cases in commercial and ...

Here’s what else you need to know to get up to speed and on with your day. 1️⃣ Epstein files. A bill requiring the Justice ...

Medicare prices are rising in 2026, but savvy seniors can save during open enrollment (and beyond) with these cost-cutting ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Flu vaccines are crucial tools in protecting public health by reducing the risk of influenza illness and its complications.

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...